WHO Drug Information, Vol. 19, No. 3, 2005                                                 Recommended INN: List 54



International Nonproprietary Names for
Pharmaceutical Substances (INN)
RECOMMENDED International Nonproprietary Names:
List 54
Notice is hereby given that, in accordance with paragraph 7 of the Procedure for the Selection of Recommended
International Nonproprietary Names for Pharmaceutical Substances [Off. Rec. Wld Health Org., 1955, 60, 3 (Resolution
EB15.R7); 1969, 173, 10 (Resolution EB43.R9)], the following names are selected as Recommended International
Nonproprietary Names. The inclusion of a name in the lists of Recommended International Nonproprietary Names does not
imply any recommendation of the use of the substance in medicine or pharmacy.
Lists of Proposed (1–91) and Recommended (1–52) International Nonproprietary Names can be found in Cumulative List
No. 11, 2004 (available in CD-ROM only).



Dénominations communes internationales
des Substances pharmaceutiques (DCI)
Dénominations communes internationales RECOMMANDÉES:
Liste 54
Il est notifié que, conformément aux dispositions du paragraphe 7 de la Procédure à suivre en vue du choix de
Dénominations communes internationales recommandées pour les Substances pharmaceutiques [Actes off. Org. mond.
Santé, 1955, 60, 3 (résolution EB15.R7); 1969, 173, 10 (résolution EB43.R9)] les dénominations ci-dessous sont choisies
par l’Organisation mondiale de la Santé en tant que dénominations communes internationales recommandées. L’inclusion
d’une dénomination dans les listes de DCI recommandées n’implique aucune recommandation en vue de l’utilisation de la
substance correspondante en médecine ou en pharmacie.
On trouvera d’autres listes de Dénominations communes internationales proposées (1–91) et recommandées (1–52) dans
la Liste récapitulative No. 11, 2004 (disponible sur CD-ROM seulement).



Denominaciones Comunes Internacionales
para las Sustancias Farmacéuticas (DCI)
Denominaciones Comunes Internacionales RECOMENDADAS:
Lista 54
De conformidad con lo que dispone el párrafo 7 del Procedimiento de Selección de Denominaciones Comunes
Internacionales Recomendadas para las Sustancias Farmacéuticas [Act. Of. Mund. Salud, 1955, 60, 3 (Resolución
EB15.R7); 1969, 173, 10 (Resolución EB43.R9)], se comunica por el presente anuncio que las denominaciones que a
continuación se expresan han sido seleccionadas como Denominaciones Comunes Internacionales Recomendadas. La
inclusión de una denominación en las listas de las Denominaciones Comunes Recomendadas no supone recomendación
alguna en favor del empleo de la sustancia respectiva en medicina o en farmacia.
Las listas de Denominaciones Comunes Internacionales Propuestas (1–91) y Recomendadas (1–52) se encuentran
reunidas en Cumulative List No. 11, 2004 (disponible sólo en CD-ROM).




                                                                                                                   243
Recommended INN: List 54                                                    WHO Drug Information, Vol. 19, No. 3, 2005




 Latin, English, French, Spanish:
 Recommended INN                    Chemical name or description; Molecular formula; Graphic formula

 DCI Recommandée                    Nom chimique ou description; Formule brute; Formule développée

 DCI Recomendada                    Nombre químico o descripción; Fórmula molecular; Fórmula desarrollada




 acidum salclobuzicum
 salclobuzic acid                          4-(4-chloro-2-hydroxybenzamido)butanoic acid

 acide salclobuzique                       acide 4-[(4-chloro-2-hydroxybenzoyl)amino]butanoïque

 ácido salclobúzico                        ácido 4-[(4-cloro-2-hidroxibenzoil)amino]butanoico

                                           C11H12ClNO4

                                                             O

                                                                  N           CO2H
                                                                  H
                                            Cl               OH



 ancrivirocum
 ancriviroc                                3-({4-[(Z)-(4-bromophenyl)(ethoxyimino)methyl]-4'-methyl-
                                           [1,4'-bipiperidin]-1'-yl}carbonyl)-2,4-dimethylpyridine-1-oxide

 ancriviroc                                4-[(Z)-(4-bromophényl)(éthoxyimino)méthyl]-1'-[(2,4-diméthyl-
                                           1-oxydopyridin-3-yl)carbonyl]-4'-méthyl-1,4'-bipipéridinyle

 ancriviroc                                4-[(Z)-(4-bromofenil)(etoxiimino)metil]-1'-[(2,4-dimetil-1-oxidopiridin-
                                           3-il)carbonil]-4'-metil-1,4'-bipipéridinilo

                                           C28H37BrN4O3

                                                                                    O   CH3
                                                                                N

                                                 O-
                                                 N+    CH3            N
                                                                                           Br
                                                                      CH3
                                                           N

                                                 CH3   O



 aplindorum
 aplindore                                 (2S)-2-[(benzylamino)methyl]-2,3,7,9-tetrahydro-8H-1,4-dioxino=
                                           [2,3-e]indol-8-one

 aplindore                                 (2S)-2-[(benzylamino)méthyl]-2,3,7,9-tétrahydro-8H-1,4-dioxino=
                                           [2,3-e]indol-8-one

 aplindor                                  (2S)-2-[(bencilamino)metil]-2,3,7,9-tetrahidro-8H-1,4-dioxino=
                                           [2,3-e]indol-8-ona




244
WHO Drug Information, Vol. 19, No. 3, 2005                                                           Recommended INN: List 54


                                             C18H18N2O3

                                              O


                                             HN                O
                                                                           N
                                                                         H H
                                                               O



 atilmotinum
 atilmotin                                   N-[(2S)-3-phenyl-2-(trimethylazaniumyl)propanoyl]-L-valyl-L-prolyl-
                                             L-isoleucyl-L-phenylalanyl-L-threonyl-L-tyrosylglycyl-L-glutamyl-
                                             L-leucyl-L-glutaminyl-D-arginyl-L-leucyl-L-lysinamide

 atilmotine                                  N-[(2S)-3-phényl-2-(triméthylammonio)propanoyl]-L-valyl-L-prolyl-
                                             L-isoleucyl-L-phénylalanyl-L-thréonyl-L-tyrosylglycyl-L-glutamyl-
                                             L-leucyl-L-glutaminyl-D-arginyl-L-leucyl-L-lysinamide

 atilmotina                                  N-[(2S)-3-fenil-2-(trimetilamonio)propanoil]-L-valil-L-prolil-L-isoleucil-
                                             L-fenilalanil-L-treonil-L-tirosilglicil-L-glutamil-L-leucil-L-glutaminil-
                                             D-arginil-L-leucil-L-lisinamida

                                             C86H134N20O19

                                                    CH3        O                                                    O
                                                                                                               H
                                             H3C N+                Val    Pro    Ile       Phe Thr Tyr   Gly   N
                                              H3C
                                                  H                                                            H

                                                                                                                   CO2-


                                             Leu    Gln    D-Arg         Leu    Lys NH2



 avanafilum
 avanafil                                    4-{[(3-chloro-4-methoxyphenyl)methyl]amino}-2-[(2S)-2-
                                             (hydroxymethyl)pyrrolidin-1-yl]-N-(pyrimidin-2-ylmethyl)pyrimidine-
                                             5-carboxamide

 avanafil                                    4-[(3-chloro-4-méthoxybenzyl)amino]-2-[(2S)-2-(hydroxyméthyl)=
                                             pyrrolidin-1-yl]-N-(pyrimidin-2-ylméthyl)pyrimidine-5-carboxamide

 avanafilo                                   4-[(3-cloro-4-metoxibencil)amino]-2-[(2S)-2-(hidroximetil)pirrolidin-
                                             1-il]-N-(pirimidin-2-ilmetil)pirimidina-5-carboxamida

                                             C23H26ClN7O3

                                                          N
                                                                         NH
                                                               N
                                                                   O                   N       H
                                                                                                   OH
                                                                         N      N          N
                                                                         H
                                             H3CO
                                                          Cl




                                                                                                                          245
Recommended INN: List 54                                       WHO Drug Information, Vol. 19, No. 3, 2005




 balicatibum
 balicatib                 N-{1-[(cyanomethyl)carbamoyl]cyclohexyl}-4-(4-propylpiperazin-
                           1-yl)benzamide

 balicatib                 N-[1-[(cyanométhyl)carbamoyl]cyclohexyl]-4-(4-propylpipérazin-
                           1-yl)benzamide

 balicatib                 N-[1-[(cianometil)carbamoil]ciclohexil]-4-(4-propilpiperazin-
                           1-il)benzamida

                           C23H33N5O2

                           H3C
                                             N
                                                      N
                                                                           O
                                                                       H
                                                                       N
                                                                               N
                                                                               H      N
                                                                   O




 becatecarinum
 becatecarin               1,11-dichloro-6-[2-(diethylamino)ethyl]-12-(4-O-methyl-
                           β-D-glucopyranosyl)-12,13-dihydro-5H-indolo[2,3-a]pyrrolo=
                           [3,4-c]carbazole-5,7(6H)-dione

 bécatécarine              1,11-dichloro-6-[2-(diéthylamino)éthyl]-12-(4-O-méthyl-
                           β-D-glucopyranosyl)-12,13-dihydro-5H-indolo[2,3-a]pyrrolo=
                           [3,4-c]carbazole-5,7(6H)-dione

 becatecarina              1,11-dicloro-6-[2-(dietilamino)etil]-12-(4-O-metil-β-D-glucopiranosil)-
                           12,13-dihidro-5H-indolo[2,3-a]pirrolo[3,4-c]carbazol-5,7(6H)-diona

                           C33H34Cl2N4O7

                             H3C         N           CH3



                                    O            N        O




                                         N           N
                                         H   OH
                             Cl                               Cl
                                                 O
                                         OH
                                  H3CO
                                                 OH




246
WHO Drug Information, Vol. 19, No. 3, 2005                                                  Recommended INN: List 54




 becocalcidiolum
 becocalcidiol                               (1R,3R)-4-(2-{(1R,3aS,7aR)-1-[(2S)-butan-2-yl]-7a-methyloctahydro-
                                             4H-inden-4-ylidene}ethylidene)-2-methylidenecyclohexane-1,3-diol

 bécocalcidiol                               (1R,3R)-2-méthylidène-5-[(2E)-2-[(1R,3aS,7aR)-7a-méthyl-
                                             1-[(1S)-1-méthylpropyl]octahydro-4H-indén-4-ylidène]éthylidène]=
                                             cyclohexane-1,3-diol

 becocalcidiol                               (1R,3R)-2-metilideno-5-[(2E)-2-[(1R,3aS,7aR)-7a-metil-
                                             1-[(1S)-1-metilpropil]octahidro-4H-inden-4-ilideno]etilideno]=
                                             ciclohexano-1,3-diol

                                             C23H36O2

                                                             H 3C H
                                                             CH3          CH3
                                                                      H


                                                             H




                                             HO                  OH
                                                  H          H
                                                      CH2



 bemotrizinolum
 bemotrizinol                                2,2'-[6-(4-methoxyphenyl)-1,3,5-triazine-2,4-diyl]bis=
                                             {5-[(2-ethylhexyl)oxy]phenol}

 bémotrizinol                                2,2'-[6-(4-méthoxyphényl)-1,3,5-triazine-2,4-diyl]bis=
                                             [5-[(2-éthylhexyl)oxy]phénol]

 bemotrizinol                                2,2'-[6-(4-metoxifenil)-1,3,5-triazina-2,4-diil]bis[5-[(2-etilhexil)=
                                             oxi]fenol]

                                             C38H49N3O5

                                                                                    OCH3




                                                                           OH   N       N   OH

                                                                                    N

                                             H3C                      O                           O                  CH3

                                                      H 3C                                                  CH3




                                                                                                                      247
Recommended INN: List 54                              WHO Drug Information, Vol. 19, No. 3, 2005




 besilesomabum
 besilesomab               immunoglobulin G1, anti-(human CEA (carcinoembryonic
                           antigen)-related antigen) (mouse monoclonal BW 250/183 heavy
                           chain), disulfide with mouse monoclonal BW 250/183 κ-chain, dimer

 bésilésomab               immunoglobuline G1, anti-(molécules de l’adhésion cellulaire,
                           antigènes carcinoembryonaires humains (CEA ou CD66)), dimère du
                           disulfure entre la chaîne lourde et la chaîne κ de l’anticorps
                           monoclonal de souris BW 250/183

 besilesomab               inmunoglobulina G1, anti-(moléculas de adhesión celular, antígenos
                           carcinoembrionarios humanos (CEA o CD66)), dímero del disulfuro
                           entre la cadena pesada y la cadena κ del anticuerpo monoclonal de
                           ratón BW 250/183




 bisoctrizolum
 bisoctrizole              2,2'-methylenebis[6-(2H-benzotriazol-2-yl)-4-(2,4,4-trimethylpentan-
                           2-yl)phenol]

 bisoctrizole              2,2'-méthylènebis[6-(2H-benzotriazol-2-yl)-4-(1,1,3,3-
                           tétraméthylbutyl)phénol]

 bisoctrizol               2,2'-metilenobis[6-(2H-benzotriazol-2-il)-4-(1,1,3,3-tetrametilbutil)=
                           fenol]

                           C41H50N6O2


                                         N     OH           OH     N
                                         N                        N
                                   N                                   N

                                         CH3                      CH3
                                H 3C             CH3 H3C               CH3
                                  H 3C          CH3   H3C             CH3



 canfosfamidum
 canfosfamide              N-γ-L-glutaminyl-3-(2-{bis[bis(2-chloroethyl)amino]=
                           phosphoryl}ethanesulfonyl)-L-alanyl-(2R)-2-phenylglycine

 canfosfamide              acide (2S)-2-amino-5-[[(1R)-1-[[[2-[[bis[bis(2-chloroéthyl)amino]=
                           phosphinoyl]oxy]éthyl]sulfonyl]méthyl]-2-[[(R)-carboxyphénylméthyl]=
                           amino]-2-oxoéthyl]amino]-5-oxopentanoïque

 canfosfamida              ácido (2S)-2-amino-5-[[(1R)-1-[[[2-[[bis[bis(2-cloroetil)amino]=
                           fosfinoil]oxi]etil]sulfonil]metil]-2-[[(R)-carboxifenilmetil]amino]-
                           2-oxoetil]amino]-5-oxopentanoico




248
WHO Drug Information, Vol. 19, No. 3, 2005                                                                      Recommended INN: List 54


                                             C26H40Cl4N5O10PS

                                                                            Cl                                 Cl
                                                                                                N
                                                                                        O       P                   Cl
                                                                                                     N
                                                                                            O
                                                                       O                                       Cl
                                                                            S
                                                                       O
                                                                   O    H               H
                                             HO2C                                       N           CO2H
                                                                       N
                                                   H NH2               H                H
                                                                                 O




 ceftobiprolum
 ceftobiprole                                (6R,7R)-7-[(2Z)-2-(5-amino-1,2,4-thiadiazol-3-yl)-2-(hydroxyimino)=
                                             acetamido]-8-oxo-3-[(E){(3'R)-2-oxo-[1,3'-bipyrrolidin]-3-ylidene}=
                                             methyl]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid

 ceftobiprole                                acide (6R,7R)-7-[[(2Z)-(5-amino-1,2,4-thiadiazol-3-yl)=
                                             (hydroxyimino)acétyl]amino]-8-oxo-3-[(E)-[(3'R)-2-oxo-
                                             1,3'-bipyrrolidinyl-3-ylidène]méthyl]-5-thia-1-azabicyclo[4.2.0]oct-
                                             2-ène-2-carboxylique

 ceftobiprol                                 ácido (6R,7R)-7-[[(2Z)-(5-amino-1,2,4-tiadiazol-3-il)(hidroxiimino)=
                                             acetil]amino]-8-oxo-3-[(E)-[(3'R)-2-oxo-1,3'-bipirrolidinil-
                                             3-ilideno]metil]-5-tia-1-azabiciclo[4.2.0]oct-2-eno-2-carboxílico

                                             C20H22N8O6S2

                                                                                    CO2H                   O
                                                               OH O
                                                           N                    N                                        NH
                                                                   H                                       N
                                                   N               N
                                                                                    S                           H
                                               S                       H H
                                                       N       O
                                             H2N



 ceftobiprolum medocarilum
 ceftobiprole medocaril                      (6R,7R)-7-[(2Z)-2-(5-amino-1,2,4-thiadiazol-3-yl)-2-(hydroxyimino)=
                                             acetamido]-3-[(E){(3'R)-1'-[(5-methyl-2-oxo-1,3-dioxol-4-yl)=
                                             methoxycarbonyl]-2-oxo-[1,3'-bipyrrolidin]-3-ylidene}methyl]-8-oxo-
                                             5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid

 ceftobiprole médocaril                      acide (6R,7R)-7-[[(2Z)-(5-amino-1,2,4-thiadiazol-3-yl)=
                                             (hydroxyimino)acétyl]amino]-3-[(E)-[(3'R)-1'-[[(5-méthyl-2-oxo-
                                             1,3-dioxol-4-yl)méthoxy]carbonyl]-2-oxo-1,3'-bipyrrolidinyl-
                                             3-ylidène]méthyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ène-
                                             2-carboxylique

 ceftobiprol medocarilo                      ácido (6R,7R)-7-[(2Z)-(5-amino-1,2,4-tiadiazol-3-il)(hidroxiimino)=
                                             acetamido]-3-[(E)-[(3'R)-1'-[[(5-metil-2-oxo-1,3-dioxol-
                                             4-il)metoxi]carbonil]-2-oxo-1,3'-bipirrolidinil-3-ilideno]metil]-8-oxo-
                                             5-tia-1-azabiciclo[4.2.0]oct-2-eno-2-carboxílico




                                                                                                                                     249
Recommended INN: List 54                                       WHO Drug Information, Vol. 19, No. 3, 2005


                             C26H26N8O11S2

                                                                CO2H        O
                                                 OH O                                         O
                                            N              N                           N
                                                     H                       N
                                   N                 N                                        O               CH3
                                                                S                H
                               S                         H H
                                        N        O
                                                                                                  O       O
                             H2N
                                                                                                      O

 cintredekinum besudotoxum
 cintredekin besudotox       toxin hIL13-PE38QQR (plasmid phuIL13-Tx)
                                   17       18
 cintrédékine bésudotox      [Met ,His ]précurseur de l’interleukine-13 humaine-(17-132)-
                             peptide (132→246')-protéine avec la
                                      365     366     367     368     369     370     371     372    373 374
                             dès-Ala ,Asp ,Val ,Val ,Ser ,Leu ,Thr ,Cys ,Pro ,Val
                                 375      376    377     378      379     380
                             ,Ala ,Ala ,Gly ,Glu ,Cys ,Ala -
                                  246     247     248     249     250     364     407     515    590
                             [Lys ,Ala ,Ser ,Gly ,Gly ,Asn ,Val ,Ser ,Gln ,
                                 606     613
                             Gln ,Arg ]exotoxine A (Pseudomonas aeruginosa)-(246-613)-
                             peptide

 cintredekina besudotox      toxina hIL13-PE38QQR (plásmido phuIL13-Tx)


                             C2234H3512N650O682S10

                             MHSPGPVPPS TALRELIEEL VNITQNQKAP LCNGSMVWSI
                             NLTAGMYCAA LESLINVSGC SAIEKTQRML SGFCPHKVSA
                             GQFSSLHVRD TKIEVAQFVK DLLLHLKKLF REGRFNKASG
                             GPEGGSLAAL TAHQACHLPL ETFTRHRQPR GWEQLEQCGY
                             PVQRLVALYL AARLSWNQVD QVIRNALASP                          GSGGDLGEAI
                             REQPEQARLA LTLAAAESER FVRQGTGNDE                          AGAANGPADS
                             GDALLERNYP TGAEFLGDGG DVSFSTRGTQ NWTVERLLQA
                             HRQLEERGYV FVGYHGTFLE AAQSIVFGGV RARSQDLDAI
                             WRGFYIAGDP ALAYGYAQDQ EPDARGRIRN GALLRVYVPR
                             SSLPGFYRTS LTLAAPEAAG EVERLIGHPL PLRLDAITGP
                             EEEGGRLETI LGWPLAERTV VIPSAIPTDP RNVGGDLDPS
                             SIPDQEQAIS ALPDYASQPG QPPREDLR

 davasaicinum
 davasaicin                  2-[4-(2-aminoethoxy)-3-methoxyphenyl]-N-[3-(3,4-dimethylphenyl)=
                             propyl]acetamide

 davasaïcine                 2-[4-(2-aminoéthoxy)-3-méthoxyphényl]-N-[3-(3,4-diméthylphényl)=
                             propyl]acétamide

 davasaicina                 2-[4-(2-aminoetoxi)-3-metoxifenil]-N-[3-(3,4-dimetilfenil)propil]=
                             acetamida

                             C22H30N2O3

                             H3C
                                                           H
                                                           N                    OCH3
                             H3C
                                                                O                       NH2
                                                                                O


250
WHO Drug Information, Vol. 19, No. 3, 2005                                                                     Recommended INN: List 54




 deferitrinum
 deferitrin                                  (4S)-2-(2,4-dihydroxyphenyl)-4-methyl-4,5-dihydro-1,3-thiazole-
                                             4-carboxylic acid

 déféritrine                                 acide (+)-(4S)-2-(2,4-dihydroxyphényl)-4-méthyl-4,5-dihydrothiazole-
                                             4-carboxylique

 deferitrina                                 ácido (+)-(4S)-2-(2,4-dihidroxifenil)-4-metil-4,5-dihidrotiazol-
                                             4-carboxílico

                                             C11H11NO4S

                                                                  H 3C
                                                                            CO2H
                                                                N

                                                                        S

                                             HO                 OH

 delmitidum
 delmitide                                   (2R)-2-[(2R)-2-{(2R)-2-[(2R)-2-{(2R)-2-[(2R)-2-(D-arginylamino)=
                                             hexanamido]hexanamido}hexanoyl-D-arginylamino]=
                                             hexanamido}hexanamido]hexanoylglycyl-D-tyrosinamide

 delmitide                                   D-arginyl-(2R)-2-aminohexanoyl-(2R)-2-aminohexanoyl-
                                             (2R)-2-aminohexanoyl-D-arginyl-(2R)-2-aminohexanoyl-
                                             (2R)-2-aminohexanoyl-(2R)-2-aminohexanoylglycyl-D-tyrosinamide

 delmitida                                   D-arginil-(2R)-2-aminohexanoil-(2R)-2-aminohexanoil-
                                             (2R)-2-aminohexanoil-D-arginil-(2R)-2-aminohexanoil-
                                             (2R)-2-aminohexanoil-(2R)-2-aminohexanoilglicil-D-tirosinamida

                                             C59H105N17O11

                                                   HN                           HN
                                                            NH2                          NH2
                                                   HN                           HN



                                                  H                     O       H              O                        O
                                                            H                            H                          H
                                                            N                            N                          N
                                             H2N                            N                          N                    NH2
                                                                    H       H                  H       H                H
                                                        O                            O                          O



                                                                  CH3                        CH3
                                                                            3                          3
                                                                                                                            OH

 deutolperisonum
                                                                    2                          2
 deutolperisone                              2-methyl-1-{4-([ H3]methyl)[2,3,5,6- H4]phenyl}-3-(piperidin-
                                             1-yl)propan-1-one
                                                                                2                          2
 deutolpérisone                              (2RS)-2-méthyl-1-(4-( H3)méthyl(2,3,5,6- H4)phényl)-3-(pipéridin-
                                             1-yl)propan-1-one
                                                                            2                      2
 deutolperisona                              (2RS)-2-metil-1-(4-[ H3]metil[2,3,5,6- H4]fenil)-3-(piperidin-
                                             1-il)propan-1-ona




                                                                                                                                    251
Recommended INN: List 54                                      WHO Drug Information, Vol. 19, No. 3, 2005


                                  2
                           C16H16 H7NO

                                             O        2
                                                          H
                                                               2
                                                                   H        and enantiomer
                                  N
                                             H                              et énantiomère
                                       H3C   2                              y enantiómero
                                                 H                 C2H3
                                                      2
                                                          H



 efipladibum
 efipladib                 4-(3-{5-chloro-2-[2-({[(3,4-dichlorophenyl)methyl]sulfonyl}amino)=
                           ethyl]-1-(diphenylmethyl)-1H-indol-3-yl}propyl)benzoic acid

 éfipladib                 acide 4-[3-[5-chloro-2-[2-[[(3,4-dichlorobenzyl)sulfonyl]amino]éthyl]-
                           1-(diphénylméthyl)-1H-indol-3-yl]propyl]benzoïque

 efipladib                 ácido 4-[3-[5-cloro-2-[2-[[(3,4-diclorobencil)sulfonil]amino]etil]-
                           1-(difenilmetil)-1H-indol-3-il]propil]benzoico

                           C40H35Cl3N2O4S

                                                                                Cl
                                                     O
                                                     O S
                                                                                 Cl
                                                        NH
                                                                                CO2H
                                        N




                                  Cl



 elomotecanum
 elomotecan                (5R)-9-chloro-5-ethyl-5-hydroxy-10-methyl-12-[(4-methylpiperidin-
                           1-yl)methyl]-1,4,5,13-tetrahydro-3H,15H-oxepino[3',4':6,7]=
                           indolizino[1,2-b]quinoline-3,15-dione

 élomotécan                (5R)-9-chloro-5-éthyl-5-hydroxy-10-méthyl-12-[(4-méthylpipéridin-
                           1-yl)méthyl]-1,4,5,13-tétrahydro-3H,15H-oxépino[3’,4’:6,7]=
                           indolizino[1,2-b]quinoléine-3,15-dione

 elomotecán                (5R)-9-cloro-5-etil-5-hidroxi-10-metil-12-[(4-metilpiperidin-1-il)metil]-
                           1,4,5,13-tetrahidro-3H,15H-oxepino[3’,4’:6,7]indolizino=
                           [1,2-b]quinolina-3,15-diona

                           C29H32ClN3O4

                                                                       O

                           H 3C          N                                       O
                                                               N
                                                                                           O


                                                          N                HO
                                  H3C                                                CH3

                                        Cl




252
WHO Drug Information, Vol. 19, No. 3, 2005                                                    Recommended INN: List 54




 embeconazolum
 embeconazole                                4-{(1E,3E)-4-(trans-5-{[(2R,3R)-3-(2,4-difluorophenyl)-3-hydroxy-
                                             4-(1H-1,2,4-triazol-1-yl)butan-2-yl]sulfanyl}-1,3-dioxan-2-yl)buta-
                                             1,3-dien-1-yl}-3-fluorobenzonitrile

 embéconazole                                (-)-4-[(1E,3E)-4-[trans-5-[[(1R,2R)-2-(2,4-difluorophényl)-2-hydroxy-
                                             1-méthyl-3-(1H-1,2,4-triazol-1-yl)propyl]sulfanyl]-1,3-dioxan-
                                             2-yl]buta-1,3-diényl]-3-fluorobenzonitrile

 embeconazol                                 (-)-4-[(1E,3E)-4-[trans-5-[[(1R,2R)-2-(2,4-difluorofenil)-2-hidroxi-
                                             1-metil-3-(1H-1,2,4-triazol-1-il)propil]sulfanil]-1,3-dioxan-2-il]buta-
                                             1,3-dienil]-3-fluorobenzonitrilo

                                             C27H25F3N4O3S

                                                                                                   F

                                                                                         F
                                                                                         HO
                                                      F                   O
                                                                      H             S
                                                                                   H
                                                                          O             H CH3 N
                                                                                                   N
                                             NC
                                                                                               N



 epoetinum zeta
 epoetin zeta                                1-165-erythropoietin (human clone B03XA01), glycoform ζ

 époétine zêta                               1-165-érythropoïétine (humaine B03XA01), glycoforme ζ

 epoetina zeta                               1-165-eritropoyetina (humana B03XA01), glicoforma ζ

                                             C809H1301N229O240S5




 eritoranum
 eritoran                                    2-deoxy-3-O-[(3R)-3-methoxydecyl]-6-O-methyl-2-(octadec-
                                             11-enamido)-4-O-phosphono-β-D-glucopyranosyl-(1→6)-3-O-decyl-
                                             2-deoxy-2-(3-oxotetradecanamido)-α-D-glucopyranose
                                             1-(dihydrogen phosphate)

 éritoran                                    dihydrogénophosphate de 3-O-décyl-2-désoxy-6-O-[2-désoxy-
                                             3-O-[(3R)-3-méthoxydécyl]-6-O-méthyl-2-[(11Z)-octadéc-
                                             11-énoylamino]-4-O-phosphono-β-D-glucopyranosyl]-
                                             2-[(3-oxotétradécanoyl)amino]-α-D-glucopyranosyle

 eritorán                                    dihidrógenofosfato de 3-O-decil-2-desoxi-6-O-[2-desoxi-3-O-[(3R)-3-
                                             metoxidecil]-6-O-metil-2-[(11Z)-octadec-11-enamido]-4-O-fosfono-
                                             β-D-glucopiranosil]-2-(3-oxotetradecanamido)-α-D-glucopiranosilo




                                                                                                                       253
Recommended INN: List 54                                 WHO Drug Information, Vol. 19, No. 3, 2005


                           C66H126N2O19P2

                                                         H3CO

                                                     H OCH3                                               CH3
                                                                           O O
                           H3C                                     O
                                                               O                          O
                                                     H2O3P                        O
                                                                   O       NH
                                                                             HO               O
                                                                                                  PO3H2
                                                                                  O       NH

                                                         CH3                O

                                       H3C


 etalocibum
 etalocib                  2-(3-{3-[(5-ethyl-4'-fluoro-2-hydroxy-[1,1'-biphenyl]-4-yl)oxy]propoxy}-
                           2-propylphenoxy)benzoic acid

 étalocib                  acide 2-[3-[3-[(5-éthyl-4'-fluoro-2-hydroxybiphényl-4-yl)oxy]propoxy]-
                           2-propylphénoxy]benzoïque

 etalocib                  ácido 2-[3-[3-[(5-etil-4'-fluoro-2-hidroxibifenil-4-il)oxi]propoxi]-
                           2-propilfenoxi]benzoico

                           C33H33FO6

                           F
                                             OH




                                                     O                 O              O
                                                                   H3C                         CO2H
                                                 CH3


 farampatorum
 farampator                5-[(piperidin-1-yl)carbonyl]-2,1,3-benzooxadiazole

 farampator                1-(2,1,3-benzoxadiazol-5-ylcarbonyl)pipéridine

 farampator                1-(2,1,3-benzoxadiazol-5-ilcarbonil)piperidina

                           C12H13N3O2

                                             O

                               N
                                                 N
                           O
                               N


 forodesinum
 forodesine                7-(5-amino-1,5-dideoxy-β-D-ribofuranos-1-yl)-1,5-dihydro-
                           4H-pyrrolo[3,2-d]pyrimidin-4-one

 forodésine                (-)-7-[(2S,3S,4R,5R)-3,4-dihydroxy-5-(hydroxyméthyl)pyrrolidin-2-yl]-
                           1,5-dihydro-4H-pyrrolo[3,2-d]pyrimidin-4-one

 forodesina                (-)-7-[(2S,3S,4R,5R)-3,4-dihidroxi-5-(hidroximetil)pirrolidin-2-il]-
                           1,5-dihidro-4H-pirrolo[3,2-d]pirimidin-4-ona



254
WHO Drug Information, Vol. 19, No. 3, 2005                                            Recommended INN: List 54


                                             C11H14N4O4

                                                       O
                                                                H
                                                                N
                                                   N

                                                       N
                                                       H
                                             HO        H
                                                       N




                                                    OH     OH



 galsulfasum
 galsulfase                                  N-acetylgalactosamine 4-sulfatase (human CSL4S-342 cell)

 galsulfase                                  N-acétylgalactosamine 4-sulfatase (cellule humaine CSL4S-342)

 galsulfasa                                  N-acetilgalactosamina 4-sulfatasa (célula humana CSL4S-342)

                                             C2529H3843N689O716S16

                                             AGASRPPHLV             FLLADDLGWN   DVGFHGSRIR   TPHLDALAAG
                                             GVLLDNYYTQ             PLCTPSRSQL   LTGRYQIRTG   LQHQIIWPCQ
                                             PSCVPLDEKL             LPQLLKEAGY   TTHMVGKWHL   GMYRKECLPT
                                             RRGFDTYFGY             LLGSEDYYSH   ERCTLIDALN   VTRCALDFRD
                                             GEEVATGYKN             MYSTNIFTKR   AIALITNHPP   EKPLFLYLAL
                                             QSVHEPLQVP             EEYLKPYDFI   QDKNRHHYAG   MVSLMDEAVG
                                             NVTAALKSSG             LWNNTVFIFS   TDNGGQTLAG   GNNWPLRGRK
                                             WSLWEGGVRG             VGFVASPLLK   QKGVKNRELI   HISDWLPTLV
                                             KLARGHTNGT             KPLDGFDVWK   TISEGSPSPR   IELLHNIDPN
                                             FVDSSPCPRN             SMAPAKDDSS   LPEYSAFNTS   VHAAIRHGNW
                                             KLLTGYPGCG             YWFPPPSQYN   VSEIPSSDPP   TKTLWLFDID
                                             RDPEERHDLS             REYPHIVTKL   LSRLQFYHKH   SVPVYFPAQD
                                             PRCDPKATGV             WGPWM



 glucarpidasum
 glucarpidase                                recombinant glutamate carboxypeptidase (carboxypeptidase G2)

 glucarpidase                                [405-arginine]précurseur de la carboxypeptidase G2 de
                                             Pseudomonas (RS-16), enzyme à zinc dimérique, glutamate
                                             carboxypeptidase

 glucarpidasa                                glutamato carboxipeptidasa recombinante (carboxipeptidasa G2)




                                                                                                             255
Recommended INN: List 54                           WHO Drug Information, Vol. 19, No. 3, 2005




                           C1950H3157N543O599S7 (monomer)

                           MRPSIHRTAI       AAVLATAFVA      GTALAQKRDN         VLFQAATDEQ
                           PAVIKTLEKL       VNIETGTGDA      EGIAAAGNFL         EAELKNLGFT
                           VTRSKSAGLV       VGDNIVGKIK      GRGGKNLLLM         SHMDTVYLKG
                           ILAKAPFRVE       GDKAYGPGIA      DDKGGNAVIL         HTLKLLKEYG
                           VRDYGTITVL       FNTDEEKGSF      GSRDLIQEEA         KLADYVLSFE
                           PTSAGDEKLS       LGTSGIAYVQ      VNITGKASHA         GAAPELGVNA
                           LVEASDLVLR       TMNIDDKAKN      LRFNWTIAKA         GNVSNIIPAS
                           ATLNADVRYA       RNEDFDAAMK      TLEERAQQKK         LPEADVKVIV
                           TRGRPAFNAG       EGGKKLVDKA      VAYYKEAGGT         LGVEERTGGG
                           TDAAYAALSG       KPVIESLGLP      GFGYHSDKAE         YVDISAIPRR
                           LYMARRLIMD       LGAGK


 iboctadekinum
 iboctadekin               a recombinant human interleukin-18 with 157 amino acids

 iboctadékine              interleukine-18 humaine recombinante (157 aminoacides)

 iboctadekina              interleukina-18 humana recombinante (157 aminoácidos)

                           C801H1264N212O252S10

                           YFGKLESKLS       VIRNLNDQVL      FIDQGNRPLF      EDMTDSDCRD
                           NAPRTIFIIS       MYKDSQPRGM      AVTISVKCEK      ISTLSCENKI
                           ISFKEMNPPD       NIKDTKSDII      FFQRSVPGHD      NKMQFESSSY
                           EGYFLACEKE       RDLFKLILKK      EDELGDRSIM      FTVQNED



 icomucretum
 icomucret                 (5Z,8Z,11Z,13E,15S)-15-hydroxyicosa-5,8,11,13-tetraenoic acid

 icomucret                 acide (5Z,8Z,11Z,13E,15S)-15-hydroxyicosa-5,8,11,13-tétraénoïque

 icomucret                 ácido (5Z,8Z,11Z,13E,15S)-15-hidroxiicosa-5,8,11,13-tetraenoico

                           C20H32O3

                                                                        CO2H




                                               H
                           H3C
                                              OH




256
WHO Drug Information, Vol. 19, No. 3, 2005                                                  Recommended INN: List 54


 inotuzumabum ozogamicinum
 inotuzumab ozogamicin                       immunoglobulin G4, anti-(human CD22 (antigen)) (human-mouse
                                             monoclonal G544 heavy chain), disulfide with human-mouse
                                             monoclonal G544 κ-chain, dimer, conjugate with methyl
                                             N-{(1R,4Z,8S,13E)-8-(4,6-dideoxy-4-{[(4-S-{4-[(6-deoxy-3-O-methyl-
                                             α-L-mannopyranosyl)oxy]-3-iodo-5,6-dimethoxy-2-methylbenzoyl}-
                                             4-thio-β-D-ribo-hexopyranosyl)oxy]amino}-2-O-[4-(N-
                                             ethylacetamido)-2,4-dideoxy-3-O-methyl-α-L-threo-pentopyranosyl]-
                                             β-D-glucopyranosyloxy)-13-[2-({4-[2-(1-{[4-(4-amino-
                                             4-oxobutyl)oxy]phenyl}ethylidene)hydrazinyl]-2-methyl-4-oxobutan-
                                             2-yl}disulfanyl)ethylidene]-1-hydroxy-11-oxobicyclo[7.3.1]trideca-
                                             4,9-diene-2,6-diyn-10-yl}carbamate

 inotuzumab ozogamicine                      N-[4-[4-[1-[[3-[[2-[(1R,4Z,8S,13E)-8-[[2-O-[4-(acétyléthylamino)-
                                             2,4-didésoxy-3-O-méthyl-α-L-thréo-pentopyranosyl]-4,6-didésoxy-
                                             4-[[[2,6-didésoxy-4-S-[4-[(6-désoxy-3-O-méthyl-
                                             α-L-mannopyranosyl)oxy]-3-iodo-5,6-diméthoxy-2-méthylbenzoyl]-
                                             4-thio-β-D-ribo-hexopyranosyl]oxy]amino]-β-D-glucopyranosyl]oxy]-
                                             1-hydroxy-10-[(méthoxycarbonyl)amino]-11-oxobicyclo[7.3.1]tridéca-
                                             4,9-diène-2,6-diyn-13-ylidène]éthyl]disulfanyl]-3-méthylbutanoyl]=
                                             diazanylidène]éthyl]phénoxy]butanoyl]immunoglobuline G4,
                                             anti-(antigène CD22 humain) dimère du disulfure entre la chaîne
                                             lourde et la chaîne κ de l'anticorps monoclonal de souris G544
                                             humanisé

 inotuzumab ozogamicina                      N-[4-[4-[1-[[3-[[2-[(1R,4Z,8S,13E)-8-[[2-O-[4-(acetiletilamino)-
                                             2,4-didesoxi-3-O-metil-α-L-treo-pentopiranosil]-4,6-didesoxi-
                                             4-[[[2,6-didesoxi-4-S-[4-[(6-desoxi-3-O-metil-α-L-manopiranosil)oxi]-
                                             3-iodo-5,6-dimetoxi-2-metilbenzoil]-4-tio-β-D-ribo-hexopiranosil]=
                                             oxi]amino]-β-D-glucopiranosil]oxi]-1-hidroxi-10-[(metoxicarbonil)=
                                             amino]-11-oxobiciclo[7.3.1]trideca-4,9-dieno-2,6-diino-
                                             13-ilideno]etil]disulfanil]-3-metilbutanoil]diazanilideno]etil]fenoxi]=
                                             butanoil]inmunoglobulina G4, anti-(antigeno CD22 humano) dimero
                                             del disulfuro entre la cadena pesada y la cadena κ del anticuerpo
                                             monoclonal humanizado de ratón G544


                                             C6518H10002N1738O2036S42

                                                                                                                 OH
                                                                                                    O
                                                                                             O
                                             Ig-NH2 = inotuzumab
                                                                                   H3C
                                                                                          O    N
                                                                                           CH3 H
                                                                                                    O O
                                                                                                            H
                                                                            CH3            OH                          S
                                                                                                             H3C
                                                                                  O O NH                               S
                                                              OCH3 O                                        H3C
                                                    H3CO                                                    O
                                                                        S
                                                                                  O       CH3       O
                                                                            OH                              HN
                                             HO         O O          CH3                                           N       CH3
                                                                            H3C       N         O
                                                  CH3          I


                                             H3CO       OH
                                                                                          OCH3          O
                                                                                                                       O
                                                                                            Ig      N
                                                                                                    H




                                                                                                                                 257
Recommended INN: List 54                                WHO Drug Information, Vol. 19, No. 3, 2005


 isalmadolum
 isalmadol                 3-{(1RS,2RS)-2-[(dimethylamino)methyl]-1-hydroxycyclohexyl}phenyl
                           2-hydroxybenzoate

 isalmadol                 2-hydroxybenzoate de 3-[(1RS,2RS)-2-[(diméthylamino)méthyl]-
                           1-hydroxycyclohexyl]phényle

 isalmadol                 2-hidroxibenzoato de 3-[(1RS,2RS)-2-[(dimetilamino)metil]-
                           1-hidroxiciclohexil]fenilo

                           C22H27NO4

                                                   CH3
                                                   N
                                                        CH3
                                              H
                                         HO
                                                               and enantiomer
                                                               et énantiomère
                                                               y enantiómero


                                        O

                              OH    O



 ispinesibum
 ispinesib                 N-(3-aminopropyl)-N-[(1R)-1-(3-benzyl-7-chloro-4-oxo-
                           3,4-dihydroquinazolin-2-yl)-2-methylpropyl]-4-methylbenzamide

 ispinésib                 N-(3-aminopropyl)-N-[(1R)-1-(3-benzyl-7-chloro-4-oxo-
                           3,4-dihydroquinazolin-2-yl)-2-méthylpropyl]-4-méthylbenzamide

 ispinesib                 N-(3-aminopropil)-N-[(1R)-1-(3-bencil-7-cloro-4-oxo-
                           3,4-dihidroquinazolin-2-il)-2-metilpropil]-4-metilbenzamida

                           C30H33ClN4O2


                                            H3C    CH3
                                            O
                                                    H
                                                         N         O
                                              N
                                                    N
                           H3C

                                                    NH2
                                                              Cl



 levotofisopamum
 levotofisopam             (5S)-1-(3,4-dimethoxyphenyl)-5-ethyl-7,8-dimethoxy-4-methyl-
                           5H-2,3-benzodiaxepine

 lévotofisopam             (-)-(5S)-1-(3,4-diméthoxyphényl)-5-éthyl-7,8-diméthoxy-4-méthyl-
                           5H-2,3-benzodiazépine

 levotofisopam             (-)-(5S)-1-(3,4-dimetoxifenil)-5-etil-7,8-dimetoxi-4-metil-
                           5H-2,3-benzodiazepina




258
WHO Drug Information, Vol. 19, No. 3, 2005                                                 Recommended INN: List 54


                                             C22H26N2O4

                                                                  CH3
                                                                    H
                                                                            CH3
                                             H3CO
                                                                            N
                                             H3CO                       N




                                                                        OCH3
                                                         H3CO


 linaprazanum
 linaprazan                                  8-{[(2,6-dimethylphenyl)methyl]amino}-N-(2-hydroxyethyl)-
                                             2,3-dimethylimidazo[1,2-a]pyridine-6-carboxamide

 linaprazan                                  8-[(2,6-diméthylbenzyl)amino]-N-(2-hydroxyéthyl)-
                                             2,3-diméthylimidazo[1,2-a]pyridine-6-carboxamide

 linaprazán                                  8-[(2,6-dimetilbencil)amino]-N-(2-hidroxietil)-2,3-dimetilimidazo=
                                             [1,2-a]piridina-6-carboxamida

                                             C21H26N4O2

                                                                                CH3
                                                         CH3
                                                                        N
                                                              H
                                                              N                   CH3
                                                                            N
                                                CH3

                                                                                      OH
                                                                  O         N
                                                                            H

 morphini glucuronidum
 morphine glucuronide                        3-hydroxy-17-methyl-4,5α-epoxymorphin-7-en-6α-yl
                                             β-D-glucopyranosiduronic acid

 glucuronide de morphine                     acide β-D-glucopyranosiduronique de 7,8-didéshydro-4,5α-époxy-
                                             3-hydroxy-17-méthylmorphinan-6α-yle

 glucurónido de morfina                      ácido β-D-glucopiranosidurónico de 7,8-dideshidro-4,5α-epoxi-
                                             3-hidroxi-17-metilmorfinan-6α-ilo

                                             C23H27NO9

                                                                      CH3
                                                         H        N

                                                          H



                                                          O                 H
                                             HO             H
                                                         CO2H O
                                                            O
                                                         OH
                                                    HO
                                                                  OH


                                                                                                                  259
Recommended INN: List 54                                     WHO Drug Information, Vol. 19, No. 3, 2005




 naveglitazarum
 naveglitazar              (2S)-2-methoxy-3-{4-[3-(4-phenoxyphenoxy)propoxy]phenyl}=
                           propanoic acid

 navéglitazar              acide (2S)-2-méthoxy-3-[4-[3-(4-phénoxyphénoxy)propoxy]phényl]=
                           propanoïque

 naveglitazar              ácido (2S)-2-metoxi-3-[4-[3-(4-fenoxifenoxi)propoxi]fenil]propanoico

                           C25H26O6

                                                         O          O
                                                                                   H OCH3

                                          O                                            CO2H



 omocianinum
 omocianine                2-{(1E,3E,5E)-7-[(2E)-3,3-dimethyl-5-sulfonato-1-(2-sulfonatoethyl)-
                           1,3-dihydro-2H-indol-2-ylidene]-4-methylhepta-1,3,5-trienyl}-
                           3,3-dimethyl-1-(2-sulfonatoethyl)-3H-indolium-5-sulfonate

 omocianine                trihydrogéno-2-[(1E,3E,5E)-7-[(2E)-3,3-diméthyl-5-sulfonato-
                           1-(2-sulfonatoéthyl)-1,3-dihydro-2H-indol-2-ylidène]-4-méthylhepta-
                           1,3,5-triényl]-3,3-diméthyl-1-(2-sulfonatoéthyl)-3H-indolium-
                           5-sulfonate

 omocianina                trihidrógeno-2-[(1E,3E,5E)-7-[(2E)-3,3-dimetil-5-sulfonato-
                           1-(2-sulfonatoetil)-1,3-dihidro-2H-indol-2-ilideno]-4-metilhepta-
                           1,3,5-trienil]-3,3-dimetil-1-(2-sulfonatoetil)-3H-indolio-5-sulfonato

                           C32H38N2O12S4

                                      -
                                          O3S                                            SO3-
                                                    N+                             N

                           3 H+                                    CH3
                                                           CH3            H3C
                                                         CH3                H 3C
                                  -
                                  O3S                                                    SO3-



 peliglitazarum
 peliglitazar              N-[(4-methoxyphenoxy)carbonyl]-N-[(1S)-1-{4-[2-(5-methyl-2-phenyl-
                           1,3-oxazol-4-yl)ethoxy]phenyl}ethyl]glycine

 péliglitazar              acide [[(4-méthoxyphénoxy)carbonyl][(1S)-1-[4-[2-(5-méthyl-
                           2-phényloxazol-4-yl)éthoxy]phényl]éthyl]amino]acétique

 peliglitazar              ácido [[(4-metoxifenoxi)carbonil][(1S)-1-[4-[2-(5-metil-2-feniloxazol-
                           4-il)etoxi]fenil]etil]amino]acético

                           C30H30N2O7

                                                N            O                 CO2H

                                                                           N       O
                                                O    CH3
                                                                        H CH3 O
                                                                                              OCH3



260
WHO Drug Information, Vol. 19, No. 3, 2005                                                    Recommended INN: List 54


 pemaglitazarum
 pemaglitazar                                (2S)-4-[(2-methylphenyl)sulfanyl]-2-[4-(trifluromethyl)phenoxy]=
                                             butanoic acid

 pémaglitazar                                (-)-acide (2S)-4-[(2-méthylphényl)sulfanyl]-2-[4-(trifluorométhyl)=
                                             phénoxy]butanoïque

 pemaglitazar                                (-)-ácido (2S)-4-[(2-metilfenil)sulfanil]-2-[4-(trifluorometil)fenoxi]=
                                             butanoico

                                             C18H17F3O3S

                                             F 3C                          H3C
                                                                     H CO2H

                                                                 O           S




 perflisobutanum
 perflisobutane                              1,1,1,2,3,3,3-heptafluoro-2-(trifluoromethyl)propane

 perflisobutane                              1,1,1,2,3,3,3-heptafluoro-2-(trifluorométhyl)propane

 perflisobutano                              1,1,1,2,3,3,3-heptafluoro-2-(trifluorometil)propano

                                             C4F10

                                                   F   CF3

                                             F3C        CF3



 piclozotanum
 piclozotan                                  3-chloro-4-[4-(1',2',3',6'-tetrahydro-[2,4'-bipyridin]-1'-yl)butyl]-
                                             1,4-benzoxazepin-5(4H)-one

 piclozotan                                  3-chloro-4-[4-(3',6'-dihydro-2,4'-bipyridinyl-1'(2'H)-yl)butyl]-
                                             1,4-benzoxazépin-5(4H)-one

 piclozotán                                  3-cloro-4-[4-(3',6'-dihidro-2,4'-bipiridinil-1'(2'H)-il)butil]-
                                             1,4-benzoxazepin-5(4H)-ona

                                             C23H24ClN3O2

                                                       O             Cl

                                                                 N
                                                                                 N
                                                             O

                                                                                       N




                                                                                                                       261
Recommended INN: List 54                                   WHO Drug Information, Vol. 19, No. 3, 2005


 pralatrexatum
 pralatrexate              N-{4-[1-(2,4-diaminopteridin-6-yl)pent-4-yn-2-yl]benzoyl}-L-glutamic
                           acid

 pralatrexate              acide (2S)-2-[[4-[(1RS)-1-[(2,4-diaminoptéridin-6-yl)méthyl]but-
                           3-ynyl]benzoyl]amino]pentanedioïque

 pralatrexato              ácido (2S)-2-[[4-[(1RS)-1-[(2,4-diaminopteridin-6-il)metil]but-
                           3-inil]benzoil]amino]pentanodioico

                           C23H23N7O5

                                                                      O   H CO2H

                                     NH2                                  N         and epimer at C*
                                                                          H         et l'épimère en C*
                                           N           *
                                 N                                             CO2H y el epímero en C*
                                                   H             CH
                           H2N       N     N




 radoterminum
 radotermin                growth differentiation factor 5 (human), homodimer

 radotermine               facteur 5 humain de différenciation de la croissance, homodimère
                           produit par E. coli

 radotermina               factor 5 humano de diferenciación del crecimiento homodímero
                           producido por E. coli

                           C1184H1844N330O350S22

                             PLATRQGKRP SKNLKARCSR KALHVNFKDM GWDDWIIAPL
                             EYEAFHCEGL CEFPLRSHLE PTNHAVIQTL MNSMDPESTP
                             PTCCVPTRLS PISILFIDSA NNVVYKQYED MVVESCGCR
                                                                                                    2




 raxibacumabum
 raxibacumab               immunoglobulin G1, anti-(anthrax protective antigen) (human
                           monoclonal PA heavy chain), disulfide with human monoclonal PA
                           λ-chain, dimer

 raxibacumab               immunoglobuline G1, anti-(antigen protecteur de l'anthrax), dimère
                           du disulfure entre la chaine lourde et la chaîne λ de l'anticorps
                           monoclonal humain PA

 raxibacumab               inmunoglobulina G1, anti-(antígeno protector del antrax), dímero del
                           disulfuro entre la cadena pesada y la cadena λ del anticuerpo
                           monoclonal humano PA

                           C6320H9794N1702O1998S42




262
WHO Drug Information, Vol. 19, No. 3, 2005                                                Recommended INN: List 54


 rimeporidum
 rimeporide                                  N-(aminoiminomethyl)-4,5-bis(methanesulfonyl)-2-methylbenzamide

 riméporide                                  N-carbamimidoyl-2-méthyl-4,5-bis(méthylsulfonyl)benzamide

 rimeporida                                  N-carbamimidoil-2-metil-4,5-bis(metilsulfonil)benzamida

                                             C11H15N3O5S2

                                                 O O                  O        NH
                                                     S
                                             H3C                           N        NH2
                                                                           H
                                             H3C
                                                  S                   CH3
                                                 O O




 saxagliptinum
 saxagliptin                                 (1S,3S,5S)-2-{(2S)-2-amino-2-(3-hydroxyadamantan-1-yl)acetyl}-
                                             2-azabicyclo[3.1.0]hexane-3-carbonitrile
                                                                                                 3,7
 saxagliptine                                (1S,3S,5S)-2-[(2S)-amino(3-hydroxytricyclo[3.3.1.1 ]déc-1-yl)=
                                             acétyl]-2-azabicyclo[3.1.0]hexane-3-carbonitrile
                                                                                               3,7
 saxagliptina                                (1S,3S,5S)-2-[(2S)-amino(3-hidroxitriciclo[3.3.1.1 ]dec-1-il)acetil]-
                                             2-azabiciclo[3.1.0]hexano-3-carbonitrilo

                                             C18H25N3O2

                                                         O        H CN
                                               H2N
                                                              N
                                                         H
                                                          H
                                                                          H

                                                     OH



 seliciclibum
 seliciclib                                  (2R)-2-{[6-benzylamino-9-(propan-2-yl)-9H-purin-2-yl]amino}butan-
                                             1-ol

 séliciclib                                  (-)-(2R)-2-[[6-(benzylamino)-9-(1-méthyléthyl)-9H-purin-2-yl]amino]=
                                             butan-1-ol

 seliciclib                                  (-)-(2R)-2-[[6-(bencilamino)-9-(1-metiletil)-9H-purin-2-il]amino]butan-
                                             1-ol

                                             C19H26N6O


                                                              H                H
                                                              N       N        N
                                             H3C
                                                          H       N
                                                         OH                    N
                                                                       N
                                                          H3C
                                                                      CH3



                                                                                                                     263
Recommended INN: List 54                                       WHO Drug Information, Vol. 19, No. 3, 2005




 sugammadexum
 sugammadex                cyclooctakis-(1→4)-[6-S-(2-carboxyethyl)-6-thio-α-D-glucopyranosyl]

 sugammadex                cyclooctakis-(1→4)-[6-S-(2-carboxyéthyl)-6-thio-α-D-glucopyranosyl]

 sugammadex                ciclooctakis-(1→4)-[6-S-(2-carboxietil)-6-tio-α-D-glucopiranosil]


                           C72H112O48S8

                                                                   S
                                                                           CO2H
                                                     CO2H
                                                                       O                    S
                                     S                    O                O
                                                 O
                                                                                        O
                                                           OH OH                                    CO2H
                                                        OH      HO
                           CO2H          O            OH          HO                    O

                                    O                OH                        HO                      S
                              S                      OH                        HO               O

                                         O            OH               HO               O                  CO2H
                                                        OH           HO
                              HO2C                              OH OH
                                             O
                                                                                    O
                                                          O                O                    S
                                         S                      O
                                                                           HO2C
                                                     HO2C
                                                                       S



 talabostatum
 talabostat                {(2R)-1-[(2S)-2-amino-3-methylbutanoyl]pyrrolidin-2-yl}boronic acid

 talabostat                acide [(2R)-1-[(2S)-2-amino-3-méthylbutanoyl]pyrrolidin-2-yl]=
                           boronique

 talabostat                ácido [(2R)-1-[(2S)-2-amino-3-metilbutanoil]pirrolidin-2-il]borónico

                           C9H19BN2O3

                                                       OH
                                  CH3    O       H
                                                       B
                                                              OH
                           H3C               N
                                   H NH2



 talactoferrinum alfa
 talactoferrin alfa        lactoferrin (recombinant human LF00)

 talactoferrine alfa       [11-L-thréonine,29-L-arginine]lactotransferrine humaine produite par
                           Aspergillus niger var. awamori

 talactoferrina alfa       [11-L-treonina,29-L-arginina]lactotransferrina humana producida por
                           Aspergillus niger var. awamori




264
WHO Drug Information, Vol. 19, No. 3, 2005                                                    Recommended INN: List 54


                                             C3345H5215N963O1015S37 (peptide)

                                               GRRRRSVQWC         TVSQPEATKC          FQWQRNMRRV      RGPPVSCIKR
                                               DSPIQCIQAI         AENRADAVTL          DGGFIYEAGL      APYKLRPVAA
                                               EVYGTERQPR         THYYAVAVVK          KGGSFQLNEL      QGLKSCHTGL
                                               RRTAGWNVPI                *
                                                                  GTLRPFLNWT          GPPEPIEAAV      ARFFSASCVP
                                               GADKGQFPNL         CRLCAGTGEN          KCAFSSQEPY      FSYSGAFKCL
                                               RDGAGDVAFI         RESTVFEDLS          DEAERDEYEL      LCPDNTRKPV
                                               DKFKDCHLAR         VPSHAVVARS          VNGKEDAIWN      LLRQAQEKFG
                                               KDKSPKFQLF         GSPSGQKDLL          FKDSAIGFSR      VPPRIDSGLY
                                               LGSGYFTAIQ         NLRKSEEEVA          ARRARVVWCA      VGEQELRKCN
                                               QWSGLSEGSV         TCSSASTTED          CIALVLKGEA      DAMSLDGGYV
                                               YTAGKCGLVP         VLAENYKSQQ          SSDPDPNCVD      RPVEGYLAVA
                                               VVRRSDTSLT         WNSVKGKKSC          HTAVDRTAGW              *
                                                                                                      NIPMGLLFNQ
                                               TGSCKFDEYF         SQSCAPGSDP          RSNLCALCIG      DEQGENKCVP
                                               NSNERYYGYT         GAFRCLAENA          GDVAFVKDVT      VLQNTDGNNN
                                               EAWAKDLKLA         DFALLCLDGK          RKPVTEARSC      HLAMAPNHAV
                                               VSRMDKVERL         KQVLLHQQAK          FGRNGSDCPD      KFCLFQSETK
                                               NLLFNDNTEC         LARLHGKTTY          EKYLGPQYVA      GITNLKKCST
                                               SPLLEACEFL         RK
                                                                        * glycosylation site
                                                                        * sites de glycosylation
                                                                        * posición de glicosilación


 talaglumetadum
 talaglumetad                                (1S,2S,5R,6S)-2-[(2S)-2-aminopropanamido]bicyclo[3.1.0]hexane-
                                             2,6-dicarboxylic acid

 talaglumétad                                acide (1S,2S,5R,6S)-2-[[(2S)-2-aminopropanoyl]amino]=
                                             bicyclo[3.1.0]hexane-2,6-dicarboxylique

 talaglumetad                                ácido (1S,2S,5R,6S)-2-[[(2S)-2-aminopropanoil]amino]=
                                             biciclo[3.1.0]hexano-2,6-dicarboxílico

                                             C11H16N2O5

                                                             H
                                                                   CO2H
                                                                       H
                                                     O
                                                                   H
                                             H2N
                                                       N         CO2H
                                                 H CH3 H


 tanogitranum
 tanogitran                                  N-[(2R)-2-{2-[(4-carbamimidoylanilino)methyl]-1-methyl-
                                             1H-benzimidazol-5-yl}-1-oxo-1-(pyrrolidin-1-yl)propan-2-yl]glycine

 tanogitran                                  acide [[(1R)-1-[2-[[(4-carbamimidoylphényl)amino]méthyl]-1-méthyl-
                                             1H-benzimidazol-5-yl]-1-méthyl-2-oxo-2-(pyrrolidin-1-yl)éthyl]=
                                             amino]acétique

 tanogitrán                                  ácido [[(1R)-1-[2-[[(4-carbamimidoilfenil)amino]metil]-1-metil-
                                             1H-bencimidazol-5-il]-1-metil-2-oxo-2-(pirrolidin-1-il)etil]amino]=
                                             acético




                                                                                                                   265
Recommended INN: List 54                              WHO Drug Information, Vol. 19, No. 3, 2005


                           C25H31N7O3



                                                                 N
                            HN                              O        CH3
                                             NH       N
                                                                      N    CO2H
                           H2N                                        H
                                                      N
                                                  H 3C



 tefibazumabum
 tefibazumab               immunoglobulin G1, anti-(Staphylococcus aureus protein ClfA
                           (clumping factor A)) (human-Mus musculus monoclonal Aurexis
                           heavy chain), disulfide with human-Mus musculus monoclonal
                           Aurexis κ-chain, dimer

 téfibazumab               immunoglobuline G1, anti-(protéine ClfA (facteur A d'agrégation) de
                           Staphylococcus aureus) dimère du disulfure entre la chaîne lourde et
                           la chaîne κ de l'anticorps monoclonal Mus-musculus Aurexis
                           humanisé

 tefibazumab               inmunoglobulina G1, anti-(proteína ClfA (factor A de agregación) de
                           Staphylococcus aureus) dimero del disulfuro entre la cadena pesada
                           y la cadena κ del anticuerpo monoclonal humano Mus-musculus
                           Aurexis

                           C6548H10122N1730O2034S44




 temsirolimusum
 temsirolimus              (1R,2R,4S)-4-{(2R)-2-(3S,6R,7E,9R,10R,12R,14S,15E,17E,19E,
                           21S,23S,26R,27R,34aS)-9,27-dihydroxy-10,21-dimethoxy-
                           6,8,12,14,20,26-hexamethyl-1,5,11,28,29-pentaoxo-
                           1,4,5,6,9,10,11,12,13,14,21,22,23,24,25,26,27,28,29,31,32,33,34,34
                           a-tetracosahydro-3H-23,27-epoxypyrido[2,1-c][1,4]=
                           oxazacyclohentriacontin-3-yl]propyl}-2-methoxycyclohexyl
                           3-hydroxy-2-(hydroxymethyl)-2-methylpropanoate

 temsirolimus              3-hydroxy-2-(hydroxyméthyl)-2-méthylpropanoate de (1R,2R,4S)-
                           4-[(2R)-2-[(3S,6R,7E,9R,10R,12R,14S,15E,17E,19E,21S,23S,
                           26R,27R,34aS)-9,27-dihydroxy-10,21-diméthoxy-6,8,12,14,20,26-
                           hexaméthyl-1,5,11,28,29-pentaoxo-1,4,5,6,9,10,11,12,13,14,21,22,
                           23,24,25,26,27,28,29,31,32,33,34,34a-tétracosahydro-23,27-époxy-
                           3H-pyrido[2,1-c][1,4]oxazacyclohentriacontin-3-yl]propyl]-
                           2-méthoxycyclohexyle

 temsirolimus              3-hidroxi-2-(hidroximetil)-2-metilpropanoato de (1R,2R,4S)-4-[(2R)-2-
                           [(3S,6R,7E,9R,10R,12R,14S,15E,17E,19E,21S,23S,26R,27R,34aS)-
                           9,27-dihidroxi-10,21-dimetoxi-6,8,12,14,20,26-hexametil-
                           1,5,11,28,29-pentaoxo-1,4,5,6,9,10,11,12,13,14,21,22,23,24,
                           25,26,27,28,29,31,32,33,34,34a-tetracosahidro-23,27-epoxi-
                           3H-pirido[2,1-c][1,4]oxazaciclohentriacontin-3-il]propil]-
                           2-metoxiciclohexilo




266
WHO Drug Information, Vol. 19, No. 3, 2005                                                       Recommended INN: List 54


                                             C56H87NO16

                                             HO
                                                            CH3

                                             HO
                                                  O         O
                                                        H
                                                    H
                                              H3CO
                                                                        H
                                                                            CH3
                                                                O           H O           H OH
                                                        H           H                                O
                                                                    O
                                                                                           H
                                                        N           O        H 3C    H CH3 OCH3
                                                                                      CH3
                                                                    OH  H                   H 3C H
                                                                      O                                   H
                                                        O
                                                                                                         CH3
                                                             H                   H OCH3
                                                            H 3C



 tetomilastum
 tetomilast                                  6-[2-(3,4-diethoxyphenyl)-1,3-thiazol-4-yl]pyridine-2-carboxylic acid

 tétomilast                                  acide 6-[2-(3,4-diéthoxyphényl)thiazol-4-yl]pyridine-2-carboxylique

 tetomilast                                  ácido 6-[2-(3,4-dietoxifenil)tiazol-4-il]piridina-2-carboxílico

                                             C19H18N2O4S

                                                                                          CO2H
                                             H 3C           O
                                                                                      N
                                                                                 N
                                             H 3C           O
                                                                             S



 thrombomodulinum alfa
 thrombomodulin alfa                         1-498-thrombomodulin (human clone TMP26/TMJ1 protein moiety
                                             reduced)

 thrombomoduline alfa                        [473-valine]précurseur de la thrombomoduline humaine-(19-516)-
                                             peptide (protéine soluble)

 trombomodulina alfa                         [473-valina]precursor de la trombomodulina humana-(19-516)-
                                             péptido (proteína soluble)




                                                                                                                      267
Recommended INN: List 54                               WHO Drug Information, Vol. 19, No. 3, 2005


                           C2230H3357N633O718S50

                                                    AP            AEPQPGGSQC       VEHDCFALYP
                                 *
                           GPATFLNASQ       ICDGLRGHLM            TVRSSVAADV       ISLLLNGDGG
                                                                                       **
                           VGRRRLWIGL       QLPPGCGDPK            RLGPLRGFQW       VTGDNNTSYS
                           RWARLDLNGA       PLCGPLCVAV            SAAEATVPSE       PIWEEQQCEV
                           KADGFLCEFH       FPATCRPLAV            EPGAAAAAVS       ITYGTPFAAR
                           GADFQALPVG       SSAAVAPLGL            QLMCTAPPGA       VQGHWAREAP
                           GAWDCSVENG       GCEHACNAIP            GAPRCQCPAG       AALQADGRSC
                                                     *
                           TASATQSCND LCEHFCVPNP DQPGSYSCMC ETGYRLAADQ
                           HRCEDVDDCI LEPSPCPQRC VNTQGGFECH CYPNYDLVDG
                                                  *
                           ECVEPVDPCF RANCEYQCQP LNQTSYLCVC AEGFAPIPHE
                                   *
                           PHRCQMFCNQ TACPADCDPN TQASCECPEG YILDDGFICT
                           DIDECENGGF CSGVCHNLPG TFECICGPDS ALVRHIGTDC
                                       *     * *   ** *
                           DSGKVDGGDS GSGEPPPSPT PGSTLTPPAV GLVHSG
                                                   * glycosylation sites
                                                   * sites de glycosylation
                                                   * posiciónes de glicosilación




268
WHO Drug Information, Vol. 19, No. 3, 2005                                                    Recommended INN: List 54



                                AMENDMENTS TO PREVIOUS LISTS
                        MODIFICATIONS APPORTÉES AUX LISTES ANTÉRIEURES
                            MODIFICACIONES A LAS LISTAS ANTERIORES

Proposed International Non Proprietary Names (Prop. INN): List 92
Dénominations communes internationales proposées (DCI Prop.): Liste 92
Denominaciones Comunes Internacionales Propuestas (DCI Prop.): Lista 92
(WHO Drug Information, Vol. 18, No. 4, 2004)

p. 351   suprimáse                      insértese
         temserolimusum                 temsirolimusum
         temserolimus                   temsirolimus

p. 354   thrombomodulinum alfa
         thrombomodulin alfa            replace the graphic formula by the following:
         thrombomoduline alfa           remplacer la formule développée par:
         trombomodulina alfa            sustitúyase la fórmula desarrollada por:
                                                                AP         AEPQPGGSQC       VEHDCFALYP
                                              *
                                        GPATFLNASQ      ICDGLRGHLM         TVRSSVAADV       ISLLLNGDGG
                                                                                                **
                                        VGRRRLWIGL      QLPPGCGDPK         RLGPLRGFQW       VTGDNNTSYS
                                        RWARLDLNGA      PLCGPLCVAV         SAAEATVPSE       PIWEEQQCEV
                                        KADGFLCEFH      FPATCRPLAV         EPGAAAAAVS       ITYGTPFAAR
                                        GADFQALPVG      SSAAVAPLGL         QLMCTAPPGA       VQGHWAREAP
                                        GAWDCSVENG      GCEHACNAIP         GAPRCQCPAG       AALQADGRSC
                                                                  *
                                        TASATQSCND LCEHFCVPNP DQPGSYSCMC ETGYRLAADQ
                                        HRCEDVDDCI LEPSPCPQRC VNTQGGFECH CYPNYDLVDG
                                                               *
                                        ECVEPVDPCF RANCEYQCQP LNQTSYLCVC AEGFAPIPHE
                                                *
                                        PHRCQMFCNQ TACPADCDPN TQASCECPEG YILDDGFICT
                                        DIDECENGGF CSGVCHNLPG TFECICGPDS ALVRHIGTDC
                                                    *     * *   ** *
                                        DSGKVDGGDS GSGEPPPSPT PGSTLTPPAV GLVHSG
                                                            * glycosylation sites
                                                            * sites de glycosylation
                                                            * posiciónes de glicosilación


Recommended International Nonproprietary Names (Rec. INN): List 16
Dénominations communes internationales recommandées (DCI Rec.): Liste 16
Denominaciones Comunes Internacionales Recomendadas (DCI Rec.): Lista 16
(WHO Drug Information, Vol. 30, No. 10, 1976)

p. 6     nosiheptidum
         nosiheptide                    replace the molecular formula by the following:
         nosiheptide                    remplacer la formule brute par:
         nosiheptida                    sustitúyase la fórmula empírica por:
                                        C51H43N13O12S6

Recommended International Nonproprietary Names (Rec. INN): List 34
Dénominations communes internationales recommandées (DCI Rec.): Liste 34
Denominaciones Comunes Internacionales Recomendadas (DCI Rec.): Lista 34
(WHO Drug Information, Vol. 8, No. 3, 1994)

p. 5     suprimase                      insértese
         bosentano                      bosentán


                                                                                                                   269
Recommended INN: List 54                                                  WHO Drug Information, Vol. 19, No. 3, 2005




Recommended International Nonproprietary Names (Rec. INN): List 52
Dénominations communes internationales recommandées (DCI Rec.): Liste 52
Denominaciones Comunes Internacionales Recomendadas (DCI Rec.): Lista 52
(WHO Drug Information, Vol. 18, No. 3, 2004)

p. 252   suprimáse                    insértese
         esoxybutynina                esoxibutinina

p. 258   suprimáse                    insértese
         ramelteòn                    ramelteón



Recommended International Nonproprietary Names (Rec. INN): List 53
Dénominations communes internationales recommandées (DCI Rec.): Liste 53
Denominaciones Comunes Internacionales Recomendadas (DCI Rec.): Lista 53
(WHO Drug Information, Vol. 19, No. 1, 2005)

p. 74    dasantafilum
         dasantafil                   replace the chemical name by the following:
                                      7-(3-bromo-4-methoxyphenylmethyl)-1-ethyl-8-{[(1R,2R)-2-hydroxycyclopentyl]=
                                      amino}-3-(2-hydroxyethyl)-3,7-dihydro-1H-purine-2,6-dione

p. 75    deluceminum
         delucemine                   replace the molecular formula by the following:
         délucémine                   remplacer la formule brute par:
         delucemina                   sustitúyase la fórmula empírica por:
                                      C16H17F2N



p. 84    maravirocum
         maraviroc                    replace the chemical name by the following:
                                      4,4-difluoro-N-[(1S)-3-{(1R,3s,5S)-3-[3-methyl-5-(propan-2-yl)-4H-1,2,4-triazol-
                                      4-yl]-8-azabicyclo[3.2.1]octan-8-yl}-1-phenylpropyl]cyclohexanecarboxamide




 Procedure and Guiding Principles / Procédure et Directives / Procedimientos y principios generales
 The text of the Procedures for the Selection of Recommended International Nonproprietary Names for Pharmaceutical
 Substances and General Principles for Guidance in Devising International Nonproprietary Names for Pharmaceutical
 Substances will be reproduced in proposed INN lists only.
 Les textes de la Procédure à suivre en vue du choix de dénominations communes internationales recommandées pour les
 substances pharmaceutiques et des Directives générales pour la formation de dénominations communes internationales
 applicables aux substances pharmaceutiques seront publiés seulement dans les listes des DCI proposées.
 El texto de los Procedimientos de selección de denominaciones comunes internacionales recomendadas para las sustancias
 farmacéuticas y de los Principios generales de orientación para formar denominaciones comunes internacionales para
 sustancias farmacéuticas aparece solamente en las listas de DCI propuestas.




270
